Gyre Therapeutics, Inc.GYRENASDAQ
Loading
Operating Cash Flow Growth AcceleratingAccelerating
Percentile Rank93
3Y CAGR+4.2%
Year-over-Year Change
Year-over-year operating cash flow growth rate
3Y CAGR
+4.2%/yr
Annual compound
Percentile
P93
Near historical high
vs 3Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 127.74% |
| 2024 | -114.06% |
| 2023 | 142.50% |
| 2022 | 112.75% |
| 2021 | -52.15% |
| 2020 | -26.22% |
| 2019 | -52.74% |
| 2018 | -43.19% |
| 2017 | -7.95% |
| 2016 | 3.38% |